264 related articles for article (PubMed ID: 30267321)
41. Recombinant human C1 esterase inhibitor in the management of hereditary angioedema.
Riedl M
Clin Drug Investig; 2015 Jul; 35(7):407-17. PubMed ID: 26091744
[TBL] [Abstract][Full Text] [Related]
42. Factor VII activating protease (FSAP) is not essential in the pathophysiology of angioedema in patients with C1 inhibitor deficiency.
Gramstad OR; Kandanur SPS; Etscheid M; Nielsen EW; Kanse SM
Mol Immunol; 2022 Feb; 142():95-104. PubMed ID: 34973499
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of lanadelumab in acquired angioedema with C1-inhibitor deficiency.
Belbézier A; Boccon-Gibod I; Bouillet L
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2490-2491. PubMed ID: 33556593
[No Abstract] [Full Text] [Related]
44. Pathogenic variant in
Kron K; Joshi S
BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37923334
[TBL] [Abstract][Full Text] [Related]
45. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
46. Lanadelumab in Patients 2 to Less Than 12 Years Old With Hereditary Angioedema: Results From the Phase 3 SPRING Study.
Maurer M; Lumry WR; Li HH; Aygören-Pürsün E; Busse PJ; Jacobs J; Nurse C; Ahmed MA; Watt M; Yu M;
J Allergy Clin Immunol Pract; 2024 Jan; 12(1):201-211.e6. PubMed ID: 37730089
[TBL] [Abstract][Full Text] [Related]
47. Gene therapy for C1 esterase inhibitor deficiency in a Murine Model of Hereditary angioedema.
Qiu T; Chiuchiolo MJ; Whaley AS; Russo AR; Sondhi D; Kaminsky SM; Crystal RG; Pagovich OE
Allergy; 2019 Jun; 74(6):1081-1089. PubMed ID: 30059156
[TBL] [Abstract][Full Text] [Related]
48. Biological therapy in hereditary angioedema: transformation of a rare disease.
Longhurst H; Farkas H
Expert Opin Biol Ther; 2020 May; 20(5):493-501. PubMed ID: 31994957
[No Abstract] [Full Text] [Related]
49. Oral plasma kallikrein inhibitor BCX7353 for treatment of hereditary angioedema.
Hwang JR; Hwang G; Johri A; Craig T
Immunotherapy; 2019 Dec; 11(17):1439-1444. PubMed ID: 31635497
[TBL] [Abstract][Full Text] [Related]
50. A Nationwide Study of Norwegian Patients with Hereditary Angioedema with C1 Inhibitor Deficiency Identified Six Novel Mutations in SERPING1.
Johnsrud I; Kulseth MA; Rødningen OK; Landrø L; Helsing P; Waage Nielsen E; Heimdal K
PLoS One; 2015; 10(7):e0131637. PubMed ID: 26154504
[TBL] [Abstract][Full Text] [Related]
51. Hereditary angioedema in a single family with specific mutations in both plasminogen and SERPING1 genes.
Bork K; Zibat A; Ferrari DM; Wollnik B; Schön MP; Wulff K; Lippert U
J Dtsch Dermatol Ges; 2020 Mar; 18(3):215-223. PubMed ID: 32065705
[TBL] [Abstract][Full Text] [Related]
52. Berotralstat: First Approval.
Lee A
Drugs; 2021 Feb; 81(3):405-409. PubMed ID: 33646555
[TBL] [Abstract][Full Text] [Related]
53. Bradykinin-mediated diseases.
Kaplan AP
Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
[TBL] [Abstract][Full Text] [Related]
54. C1-esterase inhibitor (Cinryze
Gupta R; Balduzzi J; Davis-Lorton M
Immunotherapy; 2018 Jun; 10(8):635-642. PubMed ID: 29569504
[TBL] [Abstract][Full Text] [Related]
55. Real-world changes in costs over time among patients in the United States with hereditary angioedema on long-term prophylaxis with lanadelumab.
Shah CH; Princic N; Evans KA; Schultz BG
J Med Econ; 2023; 26(1):871-877. PubMed ID: 37395381
[TBL] [Abstract][Full Text] [Related]
56. The real life experience goes on: update after 4 years on the first cohort treated with lanadelumab at our center.
Buttgereit T; Vera Ayala C; Aykanat S; Weller K; Gutsche A; Maurer M; Magerl M
Front Immunol; 2024; 15():1405317. PubMed ID: 38799421
[TBL] [Abstract][Full Text] [Related]
57. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
[TBL] [Abstract][Full Text] [Related]
58. Recent advances in the management of hereditary angioedema.
Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
[TBL] [Abstract][Full Text] [Related]
59. Hereditary angiodema: a current state-of-the-art review, VI: novel therapies for hereditary angioedema.
Frank MM
Ann Allergy Asthma Immunol; 2008 Jan; 100(1 Suppl 2):S23-9. PubMed ID: 18220149
[TBL] [Abstract][Full Text] [Related]
60. A missense mutation in the plasminogen gene, within the plasminogen kringle 3 domain, in hereditary angioedema with normal C1 inhibitor.
Dewald G
Biochem Biophys Res Commun; 2018 Mar; 498(1):193-198. PubMed ID: 29548426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
